HCPCS code A9573: Gadopiclenol injection, per 1 mL2026 Medicare rate & RVUs

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

What A9573 covers

Gadopiclenol, marketed as Vueway, is an intravenous gadolinium-based contrast agent used during MRI to improve visualization of abnormalities in the central nervous system or body. Imaging departments and other providers administering contrast report the drug alongside the applicable MRI service. The drug code identifies the contrast agent and does not represent the scan or its interpretation.

Medicare assigns this code physician fee schedule status X: gadopiclenol is not a physician service under the Medicare statute, so the physician fee schedule does not pay it. When covered, it is paid under another fee schedule or payment system; HCPCS classifies it as a Part B drug generally priced from CMS quarterly Average Sales Price files. Coverage is left to the Medicare contractor's judgment. Each unit represents 1 mL of gadopiclenol.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where A9573 pays more and less

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

109 of 109 payment localities

A9573 rates by state

Office rate range in each state. Select a state to see its payment localities.

How the A9573 rate is calculated

Each of A9573’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

Payment rules and modifiers for A9573

A9573 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

A9573 compared with similar codes

How to choose

A9575Gadoterate injectionPer 0.1 mL

Use A9573 for gadopiclenol and A9575 for gadoterate meglumine; the codes identify different MRI contrast agents.

A9585Gadobutrol injectionPer 0.1 mL

A9585 identifies gadobutrol rather than gadopiclenol. Choose according to the drug administered.

A9579MRI contrast agentUnspecified agent, per mL

A9579 is for gadolinium-based MRI contrast without a more specific code. A9573 specifically identifies gadopiclenol.

Codes related to A9573

Related codes aren’t interchangeable: bill the code that matches the service performed.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates